Liu, Jiaqing
Zhang, Xing
Zhao, Xiangge
Ren, Jinyi
Huang, Huina
Zhang, Cheng
Chen, Xianmei
Li, Weiping
Wei, Jing
Li, Xia
Funding for this research was provided by:
National Natural Science Foundation of China (82071834, 82271839)
Liaoning Undergraduate Program for Innovation and Entrepreneurship (S202310161043)
Liaoning Undergraduate Program for Innovation and Entrepreneurship (S202310161019)
Liaoning Provincial Education Department Basic Research Project (LJ212410161034)
Liaoning Provincial Education Department Basic Research Project (LJ212410161038)
Dalian Medical University Interdisciplinary Research Cooperation Project Team Funding (JCHZ2023010)
Article History
Received: 10 December 2024
Accepted: 23 April 2025
First Online: 28 May 2025
Declarations
:
: All animal procedures were conducted in strict accordance with the guidelines established by the Experimental Animals Management Committee of Liaoning Province, China, and were approved by the Experimental Animals Welfare and Ethical Committee (Date:16. 05. 2024, No. AEE24013), Dalian Medical University. Project name: Research on Pathogenesis and Treatment of Autoimmune Diseases. Human MSCs and RA peripheral blood samples were obtained from consenting volunteers enrolled in this study at the Second Hospital of Dalian Medical University. This study was approved by the Ethics Committee of the Second Hospital of Dalian Medical University (Date: 08. 10. 2023, ethical approval number: 2023–253). Project name: Pathogenesis Research and Immunotherapy in Patients with Autoimmune Diseases.
: Not Applicable.
: The authors declare that they have competing financial interests or personal relationships that could have influenced the work reported in this paper.